Michael Vasconcelles - Dec 29, 2022 Form 4 Insider Report for ImmunoGen, Inc. (IMGN)

Role
EVP R&D & MEDICAL AFFAIRS
Signature
/s/ Renee Lentini, Attorney-in-Fact
Stock symbol
IMGN
Transactions as of
Dec 29, 2022
Transactions value $
$0
Form type
4
Date filed
1/3/2023, 04:17 PM
Previous filing
Aug 17, 2022
Next filing
Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Stock Option (Right to Buy) Award $0 +960K $0.00 960K Dec 29, 2022 Common Stock 960K $5.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.